Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Nov;29 Suppl 3(Suppl 3):S170-5.
doi: 10.3346/jkms.2014.29.S3.S170. Epub 2014 Nov 21.

Injectable tissue-engineered soft tissue for tissue augmentation

Sung-Mi Rhee  1 , Hi-Jin You  1 , Seung-Kyu Han  1
Affiliations
Review

Injectable tissue-engineered soft tissue for tissue augmentation

Sung-Mi Rhee et al. J Korean Med Sci. 2014 Nov.

Abstract

Soft tissue augmentation is a process of implanting tissues or materials to treat wrinkles or soft tissue defects in the body. Over the years, various materials have evolved to correct soft tissue defects, including a number of tissues and polymers. Autogenous dermis, autogenous fat, autogenous dermis-fat, allogenic dermis, synthetic implants, and fillers have been widely accepted for soft tissue augmentations. Tissue engineering technology has also been introduced and opened a new venue of opportunities in this field. In particular, a long-lasting filler consisting of hyaluronic acid filler and living human mesenchymal cells called "injectable tissue-engineered soft tissue" has been created and applied clinically, as this strategy has many advantages over conventional methods. Fibroblasts and adipose-derived stromal vascular fraction cells can be clinically used as injectable tissue-engineered soft tissue at present. In this review, information on the soft tissue augmentation method using the injectable tissue-engineered soft tissue is provided.

Keywords: Cell Therapy; Soft Tissue; Tissue Engineering.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Application methods for injectable tissue-engineered soft tissue using cultured fibroblasts. (A) Skin harvesting. (B) Hyaluronic (HA) filler (yellow arrow) and a cultured fibroblast pellet (black arrow). (C) Cultured fibroblasts are mixed with the HA filler. (D) The fibroblasts suspended in the HA filler are injected into the nasal dorsum.
Fig. 2
Fig. 2
A 59-yr-old woman was treated with injectable tissue-engineered soft tissue using fibroblasts for augmentation rhinoplasty. (A) Preoperative view. (B) Immediate postoperative view. (C) Two weeks after the injection. (D-F) Six, 12, and 18 months after the injection.
Fig. 3
Fig. 3
Profile views of the Fig. 2 case.
Fig. 4
Fig. 4
Deep glabellar wrinkles (arrows) of a 43-yr-old man were corrected by injecting stromal vascular fraction (SVF) cells suspended in a hyaluronic (HA) filler. (A) Preoperative view. (B) One year after the injection. (C) Three years after the injection. (D-F) Three-quarter views.
Fig. 5
Fig. 5
A 30-yr-old woman was treated with injectable tissue-engineered soft tissue using stromal vascular fraction (SVF) cells for augmentation rhinoplasty. (A) Preoperative view. (B) Six months after the injection. (C) One year after the injection. (D) Six years after the injection.
See this image and copyright information in PMC

References

    1. You HJ, Han SK, Lee JW, Chang H. Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes: a pilot study. Wound Repair Regen. 2012;20:491–499. - PubMed
    1. Han SK, You HJ. Wound coverage using advanced technology in Korea. J Korean Med Assoc. 2011;54:594–603.
    1. Jeong SH, Han SK, Kim WK. Soft tissue augmentation using in vitro differentiated adipocytes: a clinical pilot study. Dermatol Surg. 2011;37:760–767. - PubMed
    1. Boss WK, Jr, Usal H, Chernoff G, Keller GS, Lask GP, Fodor PB. Autologous cultured fibroblasts as cellular therapy in plastic surgery. Clin Plast Surg. 2000;27:613–626. - PubMed
    1. Lee TG, Chung S, Chung YK. A retrospective review of iatrogenic skin and soft tissue injuries. Arch Plast Surg. 2012;39:412–416. - PMC - PubMed

LinkOut - more resources